Class information for:
Level 1: FCRN//NEONATAL FC RECEPTOR//TARGET MEDIATED DRUG DISPOSITION

Basic class information
ID Publications Average number
of references		 Avg. shr. active
ref. in WoS
11243 931 43.9 77%


Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 2)


ID, lev.
above		 Publications Label for level above
1609 6531 FCRN//NEONATAL FC RECEPTOR//FC GAMMA RECEPTORS

Terms with highest relevance score


Rank Term Type of term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 FCRN Author keyword 158 77% 11% 106
2 NEONATAL FC RECEPTOR Author keyword 87 79% 6% 56
3 TARGET MEDIATED DRUG DISPOSITION Author keyword 33 75% 3% 24
4 ROSENSTIEL BASIC BIOMED SCI Address 15 71% 1% 12
5 FCGRT Author keyword 15 88% 1% 7
6 NEONATAL FC RECEPTOR FCRN Author keyword 15 73% 1% 11
7 CHRISTIAN DOPPLER ANTIBODY ENGN Address 13 69% 1% 11
8 IGG CATABOLISM Author keyword 11 78% 1% 7
9 ANTIBODY PHARMACOKINETICS Author keyword 6 80% 0% 4
10 IGG TRANSPORT Author keyword 5 63% 1% 5

Web of Science journal categories

Author Key Words


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class		 LCSH search Wikipedia search
1 FCRN 158 77% 11% 106 Search FCRN Search FCRN
2 NEONATAL FC RECEPTOR 87 79% 6% 56 Search NEONATAL+FC+RECEPTOR Search NEONATAL+FC+RECEPTOR
3 TARGET MEDIATED DRUG DISPOSITION 33 75% 3% 24 Search TARGET+MEDIATED+DRUG+DISPOSITION Search TARGET+MEDIATED+DRUG+DISPOSITION
4 FCGRT 15 88% 1% 7 Search FCGRT Search FCGRT
5 NEONATAL FC RECEPTOR FCRN 15 73% 1% 11 Search NEONATAL+FC+RECEPTOR+FCRN Search NEONATAL+FC+RECEPTOR+FCRN
6 IGG CATABOLISM 11 78% 1% 7 Search IGG+CATABOLISM Search IGG+CATABOLISM
7 ANTIBODY PHARMACOKINETICS 6 80% 0% 4 Search ANTIBODY+PHARMACOKINETICS Search ANTIBODY+PHARMACOKINETICS
8 IGG TRANSPORT 5 63% 1% 5 Search IGG+TRANSPORT Search IGG+TRANSPORT
9 SERUM HALF LIFE 4 42% 1% 8 Search SERUM+HALF+LIFE Search SERUM+HALF+LIFE
10 TMDD 4 56% 1% 5 Search TMDD Search TMDD

Key Words Plus


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 I RELATED RECEPTOR 225 80% 15% 141
2 PH DEPENDENT BINDING 130 97% 4% 36
3 SERUM HALF LIVES 45 90% 2% 19
4 NEONATAL FC RECEPTOR 41 33% 11% 105
5 BIDIRECTIONAL TRANSCYTOSIS 37 100% 2% 14
6 IGG TRANSPORT 36 77% 3% 24
7 SERUM HALF LIFE 26 56% 3% 31
8 MEDIATED DRUG DISPOSITION 24 47% 4% 37
9 ANTIBODY TRANSPORT 23 86% 1% 12
10 MEDIATED AUTOIMMUNE DISEASE 21 73% 2% 16

Journals

Reviews


Title Publ. year Cit. Active references % act. ref.
to same field
FcRn: the neonatal Fc receptor comes of age 2007 527 86 84%
FcRn: The Architect Behind the Immune and Nonimmune Functions of IgG and Albumin 2015 1 102 75%
Monoclonal Antibody Pharmacokinetics and Pharmacodynamics 2008 241 45 51%
Neonatal Fc Receptor: From Immunity to Therapeutics 2010 68 110 85%
Neonatal Fc receptor and IgG-based therapeutics 2011 47 69 84%
Albumin as a versatile platform for drug half-life extension 2013 36 96 41%
Neonatal Fc receptor (FcRn): a novel target for therapeutic antibodies and antibody engineering 2014 3 41 83%
Immune and non-immune functions of the (not so) neonatal Fc receptor, FcRn 2009 49 102 82%
Multiple roles for the major histocompatibility complex class I-related receptor FcRn 2000 277 116 57%
IgG Placental Transfer in Healthy and Pathological Pregnancies 2012 61 109 24%

Address terms


Rank Address term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 ROSENSTIEL BASIC BIOMED SCI 15 71% 1.3% 12
2 CHRISTIAN DOPPLER ANTIBODY ENGN 13 69% 1.2% 11
3 PHARMACOKINET PHARMACODYNAM SCI 4 27% 1.5% 14
4 DAVIS HEART LUNG 012K 4 75% 0.3% 3
5 WM KECK CELLULAR VISUALIZAT 3 24% 1.1% 10
6 DRUG DISPOSIT DEV COMMERCIALIZAT 3 42% 0.5% 5
7 ANTIBODY ENGN GRP 2 67% 0.2% 2
8 BIOL PHARMACOL TOXICOL 2 67% 0.2% 2
9 PROT INTERACT GRP 2 16% 1.3% 12
10 CLIN PHARMACOL ONCOL BUSINESS UNIT 1 100% 0.2% 2

Related classes at same level (level 1)


Rank Relatedness score Related classes
1 0.0000111759 AGALACTOSYL IGG//PROT ANALYT CHEM//IGG GLYCOSYLATION
2 0.0000099770 TGN1412//SAFETY PHARMACOLOGY//REPEAT DOSE TOXICITY STUDIES
3 0.0000081834 COCUK NOROLOJISI BD//IMMUNOGLOBLIN//ALBUMIN DISTRIBUTION
4 0.0000073984 FC GAMMA RECEPTORS//FC RECEPTOR//FC GAMMA RIIA
5 0.0000073148 ANTIBODY DRUG CONJUGATE//ANTIBODY DRUG CONJUGATES//T DM1
6 0.0000068906 BIOSIMILARS//BIOSIMILAR//ANTI ERYTHROPOIETIN ANTIBODIES
7 0.0000066036 INTERSPECIES SCALING//DMPK TRANSLAT SCI//WELL STIRRED MODEL
8 0.0000062940 ASYMMETRIC ANTIBODIES//CA215//CARBOHYDRATE ASSOCIATED EPITOPE
9 0.0000059268 JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS//NONMEM//INDIRECT RESPONSE MODELS
10 0.0000053341 SINGLE DOMAIN ANTIBODY//NANOBODY//VHH